Evidence map›Paper›PMID 36010243›Full record

ArticleDiagnostics (Basel, Switzerland)2022

A Fair Performance Comparison between Complex-Valued and Real-Valued Neural Networks for Disease Detection.

Mario Jojoa, Begonya Garcia-Zapirain, Winston Percybrooks

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mario JojoaDepartment of Electrical and Electronics Engineering, University of North, Barranquilla 080002, Colombia.ORCID 0000-0002-6578-071X
Begonya Garcia-ZapirainDepartment of Computer Science and Engineering, University of Deusto, 48007 Bilbao, Spain.ORCID 0000-0002-9356-1186
Winston PercybrooksDepartment of Electrical and Electronics Engineering, University of North, Barranquilla 080002, Colombia.ORCID 0000-0002-0169-7562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our aim is to contribute to the classification of anomalous patterns in biosignals using this novel approach. We specifically focus on melanoma and heart murmurs. We use a comparative study of two convolution networks in the Complex and Real numerical domains. The idea is to obtain a powerful approach for building portable systems for early disease detection. Two similar algorithmic structures were chosen so that there is no bias determined by the number of parameters to train. Three clinical data sets, ISIC2017, PH2, and Pascal, were used to carry out the experiments. Mean comparison hypothesis tests were performed to ensure statistical objectivity in the conclusions. In all cases, complex-valued networks presented a superior performance for the Precision, Recall, F1 Score, Accuracy, and Specificity metrics in the detection of associated anomalies. The best complex number-based classifier obtained in the Receiving Operating Characteristic (ROC) space presents a Euclidean distance of 0.26127 with respect to the ideal classifier, as opposed to the best real number-based classifier, whose Euclidean distance to the ideal is 0.36022 for the same task of melanoma detection. The 27.46% superiority in this metric, as in the others reported in this work, suggests that complex-valued networks have a greater ability to extract features for more efficient discrimination in the dataset.

Indexed as

complex numberscomplex-valued convolution neural networkscomplex-valued deep learningfair performance comparisonreal-valued neural networks

Identifiers

PMID36010243
PMCPMC9406326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.